Coherus Oncology (CHRS) EBIT Margin Growth (5y) (2019 - 2026)
Coherus Oncology (CHRS) EBIT Margin Growth (5y) (2019 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Coherus Oncology |
199.14 Mn |
32.09 Mn |
8.50 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
-9,212.00 |
| Dec 31, 2025 |
74,444.00 |
| Sep 30, 2025 |
-41,283.00 |
| Jun 30, 2025 |
-49,173.00 |
| Mar 31, 2025 |
-63,308.00 |
| Dec 31, 2024 |
-62,324.00 |
| Sep 30, 2024 |
-82,063.00 |
| Jun 30, 2024 |
-41,783.00 |
| Mar 31, 2024 |
-289,230.00 |
| Jun 30, 2022 |
397,240.00 |
| Mar 31, 2022 |
4.48 Mn |
| Dec 31, 2021 |
864,989.00 |
| Sep 30, 2021 |
-9,171.00 |
| Jun 30, 2021 |
41,836.00 |
| Mar 31, 2021 |
31,913.00 |
| Dec 31, 2020 |
52,681.00 |
| Sep 30, 2020 |
102,337.00 |
| Jun 30, 2020 |
90,591.00 |
| Mar 31, 2020 |
66,767.00 |
| Dec 31, 2019 |
44,541.00 |
